Han Zeng

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Locally Advanced

Muscle Invasive Bladder Cancer

Top Venues

British journal of cancer

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaohe Su, Kaifeng Jin, Qiji Guo, Ziyue Xu, Zhaopei Liu, Han Zeng, Yiwei Wang, Yu Zhu, Le Xu, Zewei Wang, Yuan Chang, Jiejie Xu
Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer. British journal of cancer 130 (5) (2024)
Xiaohe Su, Kaifeng Jin, Qiji Guo, Ziyue Xu, Zhaopei Liu, Han Zeng, Yiwei Wang, Yu Zhu, Le Xu, Zewei Wang, Yuan Chang, Jiejie Xu
Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer. British journal of cancer 130 (5) (2024)
Xiaohe Su, Kaifeng Jin, Qiji Guo, Ziyue Xu, Zhaopei Liu, Han Zeng, Yiwei Wang, Yu Zhu, Le Xu, Zewei Wang, Yuan Chang, Jiejie Xu
Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer. British journal of cancer 130 (5) (2024)
Xiaohe Su, Kaifeng Jin, Qiji Guo, Ziyue Xu, Zhaopei Liu, Han Zeng, Yiwei Wang, Yu Zhu, Le Xu, Zewei Wang, Yuan Chang, Jiejie Xu
Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer. British journal of cancer (2024)
Xiaohe Su, Kaifeng Jin, Qiji Guo, Ziyue Xu, Zhaopei Liu, Han Zeng, Yiwei Wang, Yu Zhu, Le Xu, Zewei Wang, Yuan Chang, Jiejie Xu
Integrative score based on CDK6, PD-L1 and TMB predicts response to platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder cancer. British journal of cancer 130 (5) (2024)
Yijia Xu, Han Zeng, Kaifeng Jin, Zhaopei Liu, Yu Zhu, Le Xu, Zewei Wang, Yuan Chang, Jiejie Xu
Immunosuppressive tumor-associated macrophages expressing interlukin-10 conferred poor prognosis and therapeutic vulnerability in patients with muscle-invasive bladder cancer. Journal for immunotherapy of cancer 10 (3) (2022)
Chunnan Liu, Zhaopei Liu, Kaifeng Jin, Han Zeng, Fei Shao, Yuan Chang, Yiwei Wang, Le Xu, Zewei Wang, Yu Zhu, Weijuan Zhang
Integrative tumour mutation burden with CD39 and PD-L1 for the prediction of response to PD-L1 blockade and adjuvant chemotherapy in muscle-invasive bladder cancer patients. British journal of cancer 127 (9) (2022)
Sen Yan, Han Zeng, Kaifeng Jin, Fei Shao, Zhaopei Liu, Yuan Chang, Yiwei Wang, Yu Zhu, Zewei Wang, Le Xu, Jiejie Xu
NKG2A and PD-L1 expression panel predicts clinical benefits from adjuvant chemotherapy and PD-L1 blockade in muscle-invasive bladder cancer. Journal for immunotherapy of cancer 10 (5) (2022)